These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34309879)

  • 1. Current status and future prospects of nanomedicine for arsenic trioxide delivery to solid tumors.
    Sönksen M; Kerl K; Bunzen H
    Med Res Rev; 2022 Jan; 42(1):374-398. PubMed ID: 34309879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Will Arsenic Trioxide Benefit Treatment of Solid Tumor by Nano- Encapsulation?
    Fu X; Li YS; Zhao J; Yu LL; Luo RG; Liang QR; Tang Q
    Mini Rev Med Chem; 2020; 20(3):239-251. PubMed ID: 31760930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maximizing arsenic trioxide's anticancer potential: Targeted nanocarriers for solid tumor therapy.
    Yang S; Raza F; Li K; Qiu Y; Su J; Qiu M
    Colloids Surf B Biointerfaces; 2024 Sep; 241():114014. PubMed ID: 38850742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide: insights into its evolution to an anticancer agent.
    Hoonjan M; Jadhav V; Bhatt P
    J Biol Inorg Chem; 2018 May; 23(3):313-329. PubMed ID: 29396610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can arsenic do anything good? Arsenic nanodrugs in the fight against cancer - last decade review.
    Komorowicz I; Hanć A
    Talanta; 2024 Aug; 276():126240. PubMed ID: 38754186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harness arsenic in medicine: current status of arsenicals and recent advances in drug delivery.
    Liu F; Deng Y; Wang A; Yang T; Ke H; Tang Y; Wu H; Chen H
    Expert Opin Drug Deliv; 2024 Jun; 21(6):867-880. PubMed ID: 38913024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarrier-based delivery of arsenic trioxide for hepatocellular carcinoma therapy.
    Sun J; Cheng M; Ye T; Li B; Wei Y; Zheng H; Zheng H; Zhou M; Piao JG; Li F
    Nanomedicine (Lond); 2022 Nov; 17(26):2037-2054. PubMed ID: 36789952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of arsenic-metal complexes loaded nanodrugs for solid tumor therapy: A mini review.
    Fei W; Li C; Tao J; Cai X; Yao W; Ye Y; Zhang Y; Yao Y; Song Q; Li F; Zheng C
    Int J Pharm; 2020 Jun; 583():119385. PubMed ID: 32376447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silica nanovehicles endow arsenic trioxide with an ability to effectively treat cancer cells and solid tumors.
    Zhao Z; Zhang H; Chi X; Li H; Yin Z; Huang D; Wang X; Gao J
    J Mater Chem B; 2014 Oct; 2(37):6313-6323. PubMed ID: 32262148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide as a novel anti-glioma drug: a review.
    Fang Y; Zhang Z
    Cell Mol Biol Lett; 2020; 25():44. PubMed ID: 32983240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balance between the toxicity and anticancer activity of arsenic trioxide in treatment of acute promyelocytic leukemia.
    Wang QQ; Hua HY; Naranmandura H; Zhu HH
    Toxicol Appl Pharmacol; 2020 Dec; 409():115299. PubMed ID: 33091440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide.
    Chen H; Ahn R; Van den Bossche J; Thompson DH; O'Halloran TV
    Mol Cancer Ther; 2009 Jul; 8(7):1955-63. PubMed ID: 19567824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancers.
    Akhtar A; Xiaoyan Wang S; Ghali L; Bell C; Wen X
    J Biomed Res; 2017 Jan; 31(3):177-188. PubMed ID: 28808212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Treatment of Acute Promyelocytic Leukemia Complicated with Endometrial Cancer by Arsenic Trioxide.
    Sugiura H; Nishimori H; Matsuoka H; Nakamura K; Fujii K; Fujii N; Matsuoka KI; Maeda Y
    Acta Med Okayama; 2021 Apr; 75(2):219-224. PubMed ID: 33953429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A candidate for lung cancer treatment: arsenic trioxide.
    Huang W; Zeng YC
    Clin Transl Oncol; 2019 Sep; 21(9):1115-1126. PubMed ID: 30756240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-activated arsenic manganite nanohybrids for visible and synergistic thermo/immuno-arsenotherapy.
    Zhai Y; Liu M; Yang T; Luo J; Wei C; Shen J; Song X; Ke H; Sun P; Guo M; Deng Y; Chen H
    J Control Release; 2022 Oct; 350():761-776. PubMed ID: 36063961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of co-administration of arsenic trioxide and Schiff base oxovanadium complex on the induction of apoptosis in acute promyelocytic leukemia cells.
    Mirjalili S; Khaleghian A; Kalalinia F
    Biometals; 2021 Oct; 34(5):1067-1080. PubMed ID: 34255251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic strategy of arsenic trioxide in the fight against cancers and other diseases.
    Wang QQ; Jiang Y; Naranmandura H
    Metallomics; 2020 Mar; 12(3):326-336. PubMed ID: 32163072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Mechanistic Insights into the Anti-cancer Mode of Arsenic Trioxide.
    Wahiduzzaman M; Ota A; Hosokawa Y
    Curr Cancer Drug Targets; 2020; 20(2):115-129. PubMed ID: 31736446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug release.
    Chen H; MacDonald RC; Li S; Krett NL; Rosen ST; O'Halloran TV
    J Am Chem Soc; 2006 Oct; 128(41):13348-9. PubMed ID: 17031934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.